Metoprolol + metoprolol plus morphine
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Coronary Syndromes
Conditions
Acute Coronary Syndromes
Trial Timeline
— → —
NCT ID
NCT00718406About Metoprolol + metoprolol plus morphine
Metoprolol + metoprolol plus morphine is a approved stage product being developed by AstraZeneca for Acute Coronary Syndromes. The current trial status is completed. This product is registered under clinical trial identifier NCT00718406. Target conditions include Acute Coronary Syndromes.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00718406 | Approved | Completed |
Competing Products
20 competing products in Acute Coronary Syndromes